Filed before 2025Filed 26 August 2022
InGel Therapeutics, Inc. raised $350K
InGel Therapeutics, Inc., a biotech company based in Cambridge, MA, raised $350K in a new equity round, according to a filing dated 26 August 2022.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 26 August 2022
- Round
- Equity round
- Amount sold
- $350K
- Offering size
- $1M
- Investors so far
- 4
- Based in
- Cambridge, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 3% of the 1,764 tracked raises with an amount filed in 2022, and than 1% of the 142 in biotech.
InGel Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 26 Aug 2022 | New filing | $350K | This raise |
More with Tale on the board
- SparkCharge, Inc.$13.3M
- Endiatx, Inc.$1.37M
- Rabble Holdings, Inc.$600K
- Perthera, Inc.$750K
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.